临床药理学分析服务
The experience you need to make rapid “go/no-go” decisions
We inform decision-making and accelerate development by navigating the complexities of early phase studies, anticipating risks and opportunities and applying data-driven insights.
Built for success
Fortrea拥有超过250名全身心投入到早期阶段研究的团队成员。
Deep experience
Our clinical pharmacology team brings over 30 years of direct drug development experience.
A vast site network
通过遍布全球的300多个研究中心优化您的早期阶段研究。
Informed decisions for asset development
Fortrea provides the link between preclinical data and new treatments for patients. Our dedicated scientists and clinicians deliver comprehensive drug safety, tolerability, pharmacokinetic and pharmacodynamic data-and a complete in-house team to enable you to scrutinize development progress and deliver unique insights that inform critical decisions. As one of the largest early stage clinical research organizations in the world, we offer a comprehensive suite of pharmacology services to manage every step of your early clinical development.
The expertise to manage complexities
As we manage the conduct of your complex study, we never take our eyes off the two critical focal points-scientific integrity and human subject safety. Fortrea is built to manage the ever-growing complexity of product development with end-to-end patient safety solutions. Our integrated clinical study platform handles multisite hybrid study designs, rapid-sequence dose escalations, sophisticated biomarker or imaging exploratory endpoints, extemporaneous investigational product preparation and more.
Early phase experience that matters
In the past five years we have:
A flexible model delivers the right support
您只需要获取对您的研究最为重要的资源，完全无需打理毫无必要的一大摊事务。我们完全理解。正因如此，我们将策略和执行，资源和工具进行妥善组合并交付给您，帮您达成最终目标。
We offer you a deep, experienced team focused on this crucial phase of molecule development and deliver results as you introduce your compound in humans and move to proof-of-concept.与我们合作，转向临床试验，并着眼于未来的各个阶段。
